Results 61 to 70 of about 12,085 (139)

Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancer. [PDF]

J Manag Care Spec Pharm
Kamat S, Brown BR, Cohen SA, Vyas A.
europepmc   +1 more source

Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine. [PDF]

Arch Razi Inst, 2021
Sharun K, Jambagi K, Arya M, Aakanksha, Chaithra SN, Patel PK, Dixit SK, Dhama K.   +7 more
europepmc   +1 more source

Correction: Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR. [PDF]

Cell Death Dis
Zhang XW, Li L, Hu WQ, Hu MN, Tao Y, Hu H, Miao XK, Yang WL, Zhu Q, Mou LY.   +9 more
europepmc   +1 more source

Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment. [PDF]

Biomed Pharmacother, 2021
Mehboob R.
europepmc   +1 more source

Efficacy of <i>Rosmarinus officinalis</i> nanoemulsion as an anti-inflammatory and antinociceptive agent by targeting the interleukin-1β, substance P, and neurokinin-1 receptor pathways in experimental pulpitis. [PDF]

Open Vet J
Nugraeni Y, Putri AH, Kamaruzzaman AR, Virigirinia RP, Priyanto R, Riyawan W.   +5 more
europepmc   +1 more source

Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link? [PDF]

Front Med (Lausanne), 2021
Mehboob R, Kurdi M, Bamaga A, Aldardeir N, Nasief H, Moshref LH, Alsinani T, Rayes AO, Jabbad RH.   +8 more
europepmc   +1 more source

Effect of Neurokinin-1 Receptor Antagonists on Experimental Postoperative Adhesion: A Systematic Review and Meta-Analysis with Trial Sequential Analysis of Preclinical Studies. [PDF]

Medicina (Kaunas)
Hwang HJ, Choi GJ, Choi YS, Kim BG, Kang H.   +4 more
europepmc   +1 more source

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index. [PDF]

Int J Breast Cancer, 2022
Al-Keilani MS, Elstaty R, Alqudah MA.
europepmc   +1 more source

The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis. [PDF]

Biomed Res Int, 2022
Alsaeed MA, Ebrahimi S, Alalikhan A, Alalikhan A, Hashemi SF, Hashemy SI.   +5 more
europepmc   +1 more source

Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma. [PDF]

Cancers (Basel)
Muñoz M, Rosso M.
europepmc   +1 more source